Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Candida krusei Forms Trigger Distinct BMEC Apoptosis
2026-09-04
Miao et al. showed that the yeast and hypha phases of Candida krusei both induce apoptosis in bovine mammary epithelial cells, but through different signaling routes. The phase-specific distinction between mitochondrial and death ligand/receptor mechanisms provides a more precise framework for studying fungal mastitis and designing pathway-resolved experiments.
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-09-04
Wang et al. showed that genotype III grass carp reovirus GCRV104 enters grass carp kidney cells through a dynamin-dependent, clathrin-mediated endocytic route that requires endosomal acidification. By combining inhibitor profiling, transmission electron microscopy, and quantitative PCR, the study positioned Rottlerin-sensitive protein kinase C signaling as a potential regulator of viral entry and replication.
Cucurbitacin I: Designing Causal STAT3 Assays
2026-09-03
Cucurbitacin I and JSI-124 can do more than generate a phospho-STAT3 readout. This guide presents a layered, context-aware assay strategy that connects pathway suppression with invasion, apoptosis, autophagy, and tumor growth inhibition in vivo.
PX-478 2HCl: Translating HIF-1α Biology
2026-09-03
A translational framework for using PX-478 2HCl to connect HIF-1α biology, tumor hypoxia, radiosensitization, metabolism, and inflammatory signaling without overstating model-specific evidence.
Dinaciclib (SCH727965) in CDK Research
2026-09-02
Dinaciclib, also called SCH727965, is a multi-CDK inhibitor for cancer research focused on cell-cycle control and apoptosis. Its reported activity against CDK1, CDK2, CDK5, and CDK9 supports mechanistic studies of Rb phosphorylation inhibition, transcriptional regulation, and apoptosis induction in cancer cells.
Dantrolene Sodium Salt: RyR2 Antagonist Guide
2026-09-02
Dantrolene sodium salt is a nanomolar ryanodine receptor antagonist that supports controlled calcium signaling modulation. This guide defines its mechanism, product benchmarks, pancreatitis research relevance, workflow parameters, and limits for CRISPR and disease-model applications.
WM-8014: From KAT6A Inhibition to Translation
2026-09-01
WM-8014 offers translational researchers a reversible, acetyl-CoA-competitive way to interrogate KAT6A/B-dependent proliferation and senescence. This article connects its biochemical mechanism with time-gated functional genomics, practical assay design, model selection, and the limitations that must be addressed before therapeutic conclusions can be drawn.
High Viscosity, P-gp, and Cancer Chemoresistance
2026-09-01
The reference study identifies extracellular fluid viscosity as a mechanical regulator of doxorubicin resistance, linking cytoskeletal remodeling and water influx to a TRPV4–YAP pathway that increases P-glycoprotein expression. Its findings provide a mechanistic framework for drug resistance research and suggest that viscosity control, mechanotransduction analysis, and transporter inhibition should be evaluated together.
Lipidated Nanophotosensitizers Disable Tumor EVs
2026-08-31
This Nature Cancer study developed a palmitic-acid-displayed nanophotosensitizer that tracks tumor extracellular vesicles (TEVs) while also accumulating inside tumor cells. Near-infrared activation generated reactive oxygen species in both compartments, producing concurrent primary-tumor photodynamic therapy and disruption of TEV-mediated metastatic communication.
ATP Workflows for TCAIM–OGDH Metabolism Studies
2026-08-31
Use ATP as both a controlled energy-state perturbation and a functional readout when studying TCAIM-mediated OGDH regulation. This workflow separates direct mitochondrial enzyme effects from ATP-dependent chaperone behavior, improving interpretation across biochemical and cell-based assays.
Omeprazole A2845: Protocol and QC Guide
2026-08-30
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, antiulcer activity studies, and related in vitro or ex vivo workflows. This guide addresses dissolution, controls, storage, and assay interpretation; the material is for scientific research only and is not a diagnostic or medical product.
TCEP hydrochloride: Reliable Assay Reductant
2026-08-29
Learn how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride), SKU B6055, can help laboratories control disulfide-dependent chemistry, redox interference, and reagent-handling variability in cell-based and biochemical workflows. This scenario-driven guide emphasizes compatibility testing, practical preparation, data interpretation, and evidence-based product selection.
Isobavachalcone Triggers Apoptosis and Pyroptosis in ATC
2026-08-28
The reference study shows that isobavachalcone suppresses anaplastic thyroid carcinoma through cell-cycle arrest and concurrent activation of apoptosis and pyroptosis. Its central mechanistic contribution is linking caspase-dependent cleavage of PARP and GSDME, suggesting that one protease axis can produce distinct but simultaneous tumor-cell death programs.
ABT-888 (Veliparib): From PARP Biology to Translation
2026-08-28
ABT-888 (Veliparib) offers translational researchers a selective PARP1/2 inhibition platform for studying DNA repair inhibition, chemotherapy and radiation sensitization, and biomarker-defined resistance. This thought-leadership analysis connects colorectal cancer and microsatellite instability models with emerging replication-stress biology in PARP-resistant ovarian cancer, while emphasizing experimental rigor and preclinical boundaries.
Microlipophagy and SCLC Radioresistance
2026-08-27
A 2026 study identifies microlipophagy-driven lipid droplet remodeling as a metabolic adaptation associated with radioresistant small-cell lung cancer. By combining imaging, lipid measurements, autophagy inhibition, and transcriptomics, the work suggests that disrupting autophagy may restore radiation sensitivity, although the findings remain preclinical.
8333 records 9/556 page Previous Next First page 上5页 678910 下5页 Last page